DORILEN

This brand name is authorized in Brazil

Active ingredients

The drug DORILEN contains a combination of these active pharmaceutical ingredients (APIs):

1 Promethazine
UNII R61ZEH7I1I - PROMETHAZINE HYDROCHLORIDE

Promethazine is a potent, long acting, antihistamine with additional anti-emetic central sedative and anti-cholinergic properties.

Read about Promethazine
2 Dipyrone
UNII 6429L0L52Y - DIPYRONE

Metamizole sodium is a pyrazolone derivative with analgesic, antipyretic and slight antiinflammatory and spasmolytic properties. It has the most potent analgesic effect of all the pyrazolone derivatives. As with other analgesics, its mechanism of action has not been elucidated in detail. It includes inhibition of prostaglandin synthesis (PGE1 and PGE2) and reversible inhibition of platelet aggregation. It inhibits cyclo-oxygenase and influences the effect of arachidonic acid.

Read about Metamizole sodium
3 Adiphenine
UNII 42B4PDY0AV - ADIPHENINE HYDROCHLORIDE
Read about Adiphenine

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Cรขmara de Regulaรงรฃo do Mercado de Medicamentos Identifier(s): 538816901111417, 538816902134410, 538816903130419

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.